Colorectal cancer and hormone replacement therapy: An unexpected finding

European Journal of Cancer Prevention

Volumn 7, Issue 6, 1998, Pages 427-438

  Franceschi, S ^a   La Vecchia, C ^a  

^a NONE

Author keywords

Colon cancer; Hormone replacement therapy; Rectal cancer; Sex hormones

Indexed keywords

ESTROGEN; SEX HORMONE;

CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; COLORECTAL CANCER; HORMONE SUBSTITUTION; HUMAN; PRIORITY JOURNAL; REVIEW; RISK MANAGEMENT;

ADULT; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; META-ANALYSIS; MIDDLE AGED;

EID: 0032420674     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-199812000-00002     Document Type: Review

References (45)

1. Adami H-O, Persson I, Hoover R, Schairer C, Bergkvist L (1989). Risk of cancer in women receiving hormone replacement therapy. Int J Cancer 44: 833-9.
2. Barrett-Connor E (1991). Postmenopausal estrogen and prevention bias. Ann Intern Med 115: 455-6.
3. Bostick RM, Potter JD, Kushi LH et al (1994). Sugar, meat and fat intake and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control 5: 38-52.
4. Calle EE, Miracle-McMahil HL, Thun MJ, Heath CW Jr (1995). Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J Natl Cancer Inst 87: 517-23.
5. Chen M-J, Longnecker MP, Morgenstern H, Lee ER, Frankl HD, Haile RW (1998). Recent use of hormone replacement therapy and the prevalence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 7:227-30.
6. Chute CG, Willett WC, Colditz GA et al (1991). A prospective study of reproductive history and exogenous estrogens on the risk of colorectal cancer in women. Epidemiology 2: 201-7.
7. Collaborative Group on Hormonal Factors in Breast Cancer (1997). Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350: 1047-59.
8. Davis FG, Furner SE, Persky V, Koch M (1989). The influence of parity and exogenous female hormones on the risk of colorectal cancer. Int J Cancer 43: 587-90.
9. Day NE, Brown CC (1980). Multi-stage models and the primary prevention of cancer. J Nat Cancer Inst 64: 977-91.
10. Fernandez E, La Vecchia C, D'Avanzo B et al (1996). Oral contraceptives, hormone replacement therapy and the risk of colorectal cancer. Br J Cancer 73: 1431-5.
11. Fernandez E, La Vecchia C, Braga C et al (1998). Hormone replacement therapy and risk of colon and rectal cancer. Cancer Epidemiol Biomarkers Prev 7: 329-33.
12. Folsom AR, Mink PJ, Sellers TA et al (1995). Hormonal replacement therapy and morbidity and mortality in prospective study of postmenopausal women. Am J Public Health 85: 1128-32.
13. Franceschi S, Bidoli E, Talamini R, Barra S, La Vecchia C (1991). Colorectal cancer in northeastern Italy: reproductive, menstrual and female hormone-related factors. Eur J Cancer 27: 604-8.
14. Franceschi S, La Vacchia C. (1998) Oral contraceptives and colorectal tumors: a review of epidemiological studies. Contraception (in press).
15. Furner SE, Davis FG, Nelson RL, Haenszel W (1989). A case-control study of large bowel cancer and hormone exposure in women. Cancer Res 49: 4936-40.
16. Gerhardsson de Verdier M, London S (1992). Reproductive factors, exogenous female hormones and colorectal cancer by subsite. Cancer Causes Control 3: 355-60.
17. Giovannucci E (1995). Insulin and colon cancer. Cancer Causes Control 6: 164-79.
18. Grodstein F, Martinez E, Platz EA et al (1998). Postmenopausal hormone use and risk for colorectal cancer and adenoma. Ann Intern Med 128: 705-12.
19. Hemminki E, Kennedy DL, Baum C, McKinlay SM (1988). Prescribing of noncontraceptive estrogens and progestin in the United States, 1974-86. Am J Public Health 78: 1479-81.
20. Herbert-Croteau N (1998). A meta-analysis of hormone replacement therapy and colon cancer among women. Am J Epidemiol 147: 87.
21. Issa JP, Ottaviano YL, Celano P et al (1994). Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nature Genet 7: 536-40.
22. Jacobs EJ, White E, Weiss NS (1994). Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA). Cancer Causes Control 5: 359-66.
23. Jacobson JS, Neugut AI, Garbowski GD et al (1995). Reproductive risk factors for colorectal adenomatous polyps (New York City, NY, United States). Cancer Causes Control 6: 513-18.
24. Kampman E, Potter JD, Slattery ML, Caan BJ, Edward S (1997). Hormone replacement therapy, reproductive history and colon cancer: a multicenter, case-control study in the United States. Cancer Causes Control 8: 146-58.
25. La Vecchia C, Franceschi S (1991). Reproductive factors and colorectal cancer. Cancer Causes Control 2: 193-200.
26. La Vecchia C, Negri E, Levi F, Decarli A, Boyle P (1998). Cancer mortality in Europe: effects of age, cohort of birth and period of death. Eur J Cancer 34: 118-41.
27. Landis SH (1998). Cancer statistics, 1998. CA Cancer J Clin 48: 6-29.
28. Martinez ME, Grodstein F, Giovannucci E et al (1997). A prospective study of reproductive factors, oral contraceptive use and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 6: 1-5.
29. McMichael AJ, Potter JD (1985). Host factors in carcinogenesis: certain bile-acid metabolic profiles that selectively increase the risk of proximal colon cancer. J Natl Cancer Inst 75: 185-91.
30. McMichael AJ, Giles GG (1994). Colorectal cancer. Cancer Surv 19: 77-98.
31. Negri E, La Vecchia C, Parazzini F et al (1989). Reproductive and menstrual factors and risk of colorectal cancer. Cancer Res 49: 7158-61.
32. Newcomb PA, Storer BE (1995). Postmenopausal hormone use and risk of large-bowel cancer. J Natl Cancer Inst 87: 1067-71.
33. Parazzini F, La Vecchia C, Negri E, Bianchi C, Fedele L (1993). Determinants of estrogen replacement therapy use in northern Italy. Rev Epidem Santé Publ 41: 53-8.
34. Persson I, Yuen J, Bergkvist L, Schairer C (1996). Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy - long-term follow-up of a Swedish cohort. Int J Cancer 67: 327-32.
35. Peters RK, Pike MC, Chang WWL, Mack TM (1990). Reproductive factors and colon cancers. Br J Cancer 61: 741-8.
36. Potter JD, McMichael AJ (1983). Large bowel cancer in women in relation to reproductive and hormonal factors: a case-control study. J Natl Cancer Inst 71: 703-9.
37. Potter JD, Bostick RM, Grandits GA et al (1996). Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota Cancer Prevention Research Unit Case-control Study. Cancer Epidemiol Biomarkers Prev 5: 779-84.
38. Risch HA, Howe GR (1995). Menopausal hormone use and colorectal cancer in Saskatchewan: a record linkage cohort study. Cancer Epidemiol Biomarkers Prev 4: 21-8.
39. Sturgeon SR, Schairer C, Brinton LA, Pearson T, Hoover RN (1995). Evidence of a healthy estrogen user survivor effect. Epidemiology 6: 227-31.
40. Talamini R, Franceschi S, Dal Maso L et al (1998). The influence of reproductive and hormonal factors on the risk of colon and rectal cancer in women. Enr J Cancer 34: 1070-6.
41. Troisi R, Schairer C, Chow W-H et al (1997). A prospective study of menopausal hormones and risk of colorectal cancer (United States). Cancer Causes Control 8: 130-8.
42. Weiss NS, Daling JR, Chow WH (1981). Incidence of cancer of the large bowel in women in relation to reproductive and hormonal factors. J Natl Cancer Inst 67: 57-60.
43. Wu AH, Paganini-Hill A, Ross RK, Henderson BE (1987). Alcohol, physical activity and other risk factors for colorectal cancer: a prospective study. Br J Cancer 55: 687-94.
44. Wu-Williams AH, Lee M, Whittemore AS et al (1991). Reproductive factors and colorectal cancer risk among Chinese females. Cancer Res 51: 2307-11.
45. Yood SM, Ulcickas Yood M, McCarthy (1998). A case-control study of hormone replacement therapy and colorectal cancer. Ann Epidemiol 8: 133.